https://www.selleckchem.com/pr....oducts/pf-3758309.ht
nesis-related biomarkers in a multiplex biomarker panel can improve the diagnostic performance of the established biomarkers HE4 and CA125. HE4 was the best performing individual biomarker for discrimination between benign ovarian tumors and EOC including borderline tumors. The addition of other carcinogenesis-related biomarkers in a multiplex biomarker panel can improve the diagnostic performance of the established biomarkers HE4 and CA125. Since the scale-up of the HIV "Treat All" recommendation, evidence on its real-world effect o
Like
Comment
Share
